Surufatinib in advanced pancreatic neuroendocrine tumours (SANET-p): a randomised, double-blind, placebo-controlled, phase 3 study-Reference-Cited by-同舟云学术

Surufatinib in advanced pancreatic neuroendocrine tumours (SANET-p): a randomised, double-blind, placebo-controlled, phase 3 study

Published:2020-11 Issue:11 Volume:21 Page:1489-1499
ISSN:1470-2045
Container-title:The Lancet Oncology
language:en
Short-container-title:The Lancet Oncology

Author:

Xu Jianming,Shen Lin,Bai Chunmei,Wang Wei,Li Jie,Yu Xianjun,Li Zhiping,Li Enxiao,Yuan Xianglin,Chi Yihebali,Yin Yongmei,Lou Wenhui,Xu Nong,Bai Yuxian,Zhang Tao,Xiu Dianrong,Wang Xiuwen,Yuan Ying,Chen Jia,Qin Shukui,Jia Ru,Lu Ming,Cheng Yuejuan,Zhou Zhiwei,Li Jing,He James,Su Weiguo

Publisher

Elsevier BV

Subject

Oncology

Reference24 articles.

1. Trends in the incidence, prevalence, and survival outcomes in patients with neuroendocrine tumors in the United States;Dasari;JAMA Oncol,2017

2. A meta-analysis of prognostic factor of pancreatic neuroendocrine neoplasms;Gao;Sci Rep,2018

3. Epidemiologic trends in neuroendocrine tumors: an examination of incidence rates and survival of specific patient subgroups over the past 20 years;Sackstein;Semin Oncol,2018

4. ENETS consensus guidelines update for the management of distant metastatic disease of intestinal, pancreatic, bronchial neuroendocrine neoplasms (NEN) and NEN of unknown primary site;Pavel;Neuroendocrinology,2016

5. Placebo-controlled, double-blind, prospective, randomized study on the effect of octreotide LAR in the control of tumor growth in patients with metastatic neuroendocrine midgut tumors: a report from the PROMID Study Group;Rinke;J Clin Oncol,2009

Cited by 116 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Case report: Surgical treatment and literature review of a recurrent case of glucagonoma;Frontiers in Oncology;2024-08-26

2. Therapeutic advances of targeting receptor tyrosine kinases in cancer;Signal Transduction and Targeted Therapy;2024-08-14

3. Management of typical and atypical metastatic lung carcinoids: present and future perspectives;Clinical and Translational Oncology;2024-08-07

4. Update in the management of gastroenteropancreatic neuroendocrine tumors;Cancer;2024-07-16

5. Case report: Remarkable response to later-line surufatinib in an adult patient with liver metastatic of pancreatoblastoma;Frontiers in Pharmacology;2024-06-14